share_log

HC Wainwright & Co. Maintains Buy on Elicio Therapeutics, Lowers Price Target to $10

Benzinga ·  May 1 06:25

HC Wainwright & Co. analyst Robert Burns maintains Elicio Therapeutics (NASDAQ:ELTX) with a Buy and lowers the price target from $11 to $10.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment